본문 바로가기
KERD
논문KCI 등재

복부비만 고령여성의 대사증후군 위험요인과 고감도 C-반응성 단백의 관련성

The Relationship between Metabolic Syndrome Risk Factors and High Sensitive C-reactive Protein in Abdominal Obesity Elderly Women

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

이 연구에서는 복부비만을 가진 고령여성을 대상으로 대사증후군 동반 유무에 따른 대사증후군 위험요인과 hs-CRP와의관련성에 대해 알아보고자 하였다. 대사증후군 진단은AHA/NHLBI (American Heart Association/National Heart, Lung and Blood Institute) 2005년 기준에 따라 5가지 기준 중3개 이상 해당되는 경우 대사증후군 진단군(MetS, N=77), 2개이하의 위험요인에 해당하는 경우 대조군(Absent, N=97)으로분류하였다. hs-CRP 농도는 대사증후군 위험요인과 밀접한 관련이 있으며, 특히 복부비만(r=0.190, p=0.014), 공복혈당(r=0.240, p=0.002), HDL-콜레스테롤(r=−0.164, p=0.035) 과 연관이 있음을 확인할 수 있었다. 또한 대조군보다 대사증후군 진단군에서 hs-CRP가 높게 나타났으며(p=0.007), 복부비만 상태일지라도 높은 혈당(p=0.006)과 낮은 HDL-콜레스테롤혈증(p=0.010)의 위험요인이 있는군에서 hs-CRP가 높았다. 결론적으로 복부비만이 있더라도 대사증후군 위험요인의 동반유무에 따라 염증관련 위험도가 달라짐을 알 수 있었다.

Abstract

High sensitive C-reactive protein (hs-CRP) has been associated with metabolic syndrome (MetS) and its risk factors. This study aimed to evaluate the association between hs-CRP and the risk factors of MetS in elderly women with abdominal obesity. The diagnosis of MetS followed the AHA/NHLBI criteria, and abdominal obesity was defined using the WHO Asian-Pacific criteria. We used the data from 174 elderly women, with an average age of 74 years. They were classified into two groups: The absent group (N=97) and the MetS group (N=77). Hs-CRP was significantly higher in the MetS group (p=0.007). Hs-CRP had a positive correlation with abdominal obesity (r=0.190, p=0.014) and fasting blood glucose (r=0.240, p=0.002), while having a negative correlation with HDL cholesterol (r=−0.164, p=0.035). Moreover, hs-CRP was higher in the group with risk of high fasting blood glucose (p=0.006) and low HDL-cholesterol (p=0.010), even in elderly women with abdominal obesity.

참고문헌 (35)

  1. Kushner I, "Regulation of the acute phase response by cytokines", Perspect Biol Med, 36(4), pp.611~622 (1993)
  2. Ridker PM, "C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus", J Am Coll Cardiol, 49(21), pp.2129~2138 (2007)
  3. Pickup JC, "Is type II diabetes mellitus a disease of the innate immune system?", Diabetologia, 41(10), pp.1241~1248 (1998)
  4. Brook RD, "Usefulness of visceral obesity (waist", hip ratio) in predicting vascular endothelial function in healthy overweight adults, 2001, pp.88(11), 1264~1269
  5. Reaven GM, "Banting lecture 1988. Role of insulin resistance in human disease", Diabetes, 37(12), pp.1595~1607 (1988)
  6. Yudkin JS, "Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?", Atherosclerosis, 148(2), pp.209~214 (2000)
  7. de Ferranti S, "C-reactive protein and cardiovascular disease: a review of risk prediction and interventions", Clin Chim Acta, 317(1-2), pp.1~15 (2002)
  8. Campos SP, "Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes", Mol Cell Biol, 12(4), pp.1789~1797 (1992)
  9. 임열리, "ATP III의 진단기준에 따른 대사증후군의 유병률과 관련위험요인 분석 -일개 대학병원 건강증진센터 수진자를 대상으로-", Korean Journal of Family Medicine, 24(2), pp.135~143 (2003), 대한가정의학회
  10. 박전수, "대사증후군과 염증관련인자로서 C-반응단백의 역할", Korean Journal of Family Medicine, 30(6), pp.449~456 (2009), 대한가정의학회
  11. Ford ES, "Body mass index, diabetes, and C-reactive protein among U.S. adults", Diabetes Care, 22(12), pp.1971~1977 (1999)
  12. Pannacciulli N, "C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women", Int J Obes Relat Metab Disord, 25(10), pp.1416~1420 (2001)
  13. Poirier P, "Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism", Circulation, 113(6), pp.898~918 (2006)
  14. Aubertin-Leheudre M, "Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women", Obesity (Silver Spring), 14(12), pp.2277~2283 (2006)
  15. Baumgartner RN, "Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly", Obes Res, 12(12), pp.1995~2004 (2004)
  16. World Health Organization, "The Asia-Pacific Perspective:Redefining obesity and its treatment", pp.19~20 (2000), Health Communications Australia
  17. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute scientific statement, 2005, pp.4(4), 198~203
  18. Tracy RP, "Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project", Arterioscler Thromb Vasc Biol, 17(6), pp.1121~1127 (1997)
  19. Koenig W, "C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992", Circulation, 99(2), pp.237~242 (1999)
  20. 김미경, "대사증후군", 대한의사협회지, 55(10), pp.1005~1013 (2012), 대한의사협회[DOI]
  21. Lovejoy JC, "The menopause and obesity", Prim Care, 30(2), pp.317~325 (2003)
  22. Fröhlich M, "Association between C-reactive protein and features of the metabolic syndrome: a population-based study", Diabetes Care, 23(12), pp.1835~1839 (2000)
  23. Danesh J, "Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses", BMJ, 321(7255), pp.199~204 (2000)
  24. Yudkin JS, "C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?", Arterioscler Thromb Vasc Biol, 19(4), pp.972~978 (1999)
  25. Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", Nat Med, 7(8), pp.941~946 (2001)
  26. Hotta K, "Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients", Arterioscler Thromb Vasc Biol, 20(6), pp.1595~1599 (2000)
  27. Yang WS, "Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin", J Clin Endocrinol Metab, 86(8), pp.3815~3819 (2001)
  28. Ouchi N, "Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages", Circulation, 103(8), pp.1057~1063 (2001)
  29. Okamoto Y, "An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls", Horm Metab Res, 32(2), pp.47~50 (2000)
  30. Kuller LH, "Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial", Am J Epidemiol, 144(6), pp.537~547 (1996)
  31. Ridker PM, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336(14), pp.973~979 (1997)
  32. Aguilar D, "Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease", Am Heart J, 152(2), pp.298~304 (2006)
  33. 김종임, "일부 농촌지역 주민들의 혈중 hs-CRP 농도와 대사증후군 위험인자와의 관계", 대한지역사회영양학회지, 15(6), pp.796~805 (2010), 대한지역사회영양학회
  34. Tchernof A, "Weight loss reduces C-reactive protein levels in obese postmenopausal women", Circulation, 105(5), pp.564~569 (2002)
  35. Laimer M, "Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention", Int J Obes Relat Metab Disord, 26(5), pp.659~662 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (14건)